Patents by Inventor Yoshihiro Morinaga

Yoshihiro Morinaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210371635
    Abstract: A resin composition including: at least one resin ingredient selected from the group made of a resin (A) having a side chain (a) containing a hydrogen-bonding cross-linking moiety with a carbonyl-containing group and/or a nitrogen-containing heterocycle and having a glass transition point of 25° C. or lower, and a resin (B) containing a hydrogen-bonding cross-linking moiety and a covalent-bonding cross-linking moiety in a side chain and having a glass transition point of 25° C. or lower, wherein both the resin (A) and the resin (B) are a reaction product of a cross-linking agent with a maleic anhydride-modified thermoplastic resin having a melting point of 68° C. to 134° C. and a maleation rate of 0.5 to 2.5% by mass.
    Type: Application
    Filed: July 30, 2019
    Publication date: December 2, 2021
    Applicant: ENEOS CORPORATION
    Inventors: Keisuke CHINO, Yoshihiro MORINAGA, Yuhei SASAKI, Takafumi ISHII, Toshiyuki IWASAKI
  • Publication number: 20210087367
    Abstract: A rubber composition includes: a rubber having no hydrogen-bond cross-linkable moiety; a specific polymer component; and a clay, wherein a content of the polymer component is 0.01 to 300 parts by mass relative to 100 parts by mass of the rubber, and an amount of the clay contained is 20 parts by mass or less relative to 100 parts by mass of the polymer component.
    Type: Application
    Filed: August 2, 2018
    Publication date: March 25, 2021
    Applicant: JXTG NIPPON OIL & ENERGY CORPORATION
    Inventors: Keisuke CHINO, Yusuke MATSUO, Yoshihiro MORINAGA, Toshiyuki TSUTSUMI
  • Publication number: 20170145277
    Abstract: Provided are a latent heat storage material that functions as a high-capacity heat storage material at a medium-to-low temperature region using a latent heat storage material composition including at least one kind of n-paraffin having 14 to 18 carbon atoms in a total amount of 100 parts by mass (hereinafter referred to as “n-paraffin-based latent heat storage material composition”) that contains, as a supercooling preventing agent, an n-alkyl alcohol and/or an n-alkyl amine having 20 to 24 carbon atoms (hereinafter referred to as “n-paraffin derivative”), and is obtained by the following a) step and b) step, a microcapsule heat storage material containing the latent heat storage material as a core material, and a method for producing the same. a) A step of melting and homogenizing the n-paraffin derivative and the n-paraffin-based latent heat storage material composition at a temperature range of 50 to 100° C.
    Type: Application
    Filed: May 7, 2015
    Publication date: May 25, 2017
    Inventors: Zhengzhe JIN, Tsutomu TAKASHIMA, Yoshihiro MORINAGA, Takahiro KAWAGUCHI
  • Publication number: 20160090521
    Abstract: A paraffin-based latent heat storage material composition is provided which has a melting point close to the melting point of n-heptadecane and has a high latent heat of fusion. The paraffin-based latent heat storage material composition of the present invention substantially includes n-octadecane, and n-hexadecane and/or n-heptadecane. The paraffin-based latent heat storage material composition contains not less than 76% by mass of n-octadecane, not more than 23% by mass of n-hexadecane, and not more than 23% by mass of n-heptadecane (the total of the three is set to 100% by mass) and has a melting point lower than that of n-octadecane and latent heat of fusion of 210 J/g or more.
    Type: Application
    Filed: December 2, 2015
    Publication date: March 31, 2016
    Applicant: JX NIPPON OIL & ENERGY CORPORATION
    Inventors: Mizuho YOSHIDA, Masaaki KOBAYASHI, Yoshihiro MORINAGA, Toshiyuki TSUTSUMI
  • Publication number: 20160083636
    Abstract: A paraffin-based composition includes: n-eicosane, and at least one of n-octadecane and n-nonadecane. (1) the paraffin-based composition contains not less than 83% by mass of n-eicosane, not more than 13% by mass of n-octadecane, and not more than 17% by mass of n-nonadecane; (2) the paraffin-based composition has a melting point lower than a melting point of n-eicosane; and (3) the paraffin-based composition has latent heat of fusion of 230 J/g or more.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Applicant: JX NIPPON OIL & ENERGY CORPORATION
    Inventors: Mizuho YOSHIDA, Masaaki KOBAYASHI, Yoshihiro MORINAGA, Toshiyuki TSUTSUMI
  • Patent number: 9271521
    Abstract: The present invention provides a prophylactic or therapeutic agent, a pharmaceutical composition and a health-promoting food, which are used for human or other animal for the inhibition of the onset or progress of liver cancer, namely, an inhibitor of the onset or progress of liver cancer, which contains isoleucine, leucine and valine as active ingredients, wherein the weight ratio of isoleucine, leucine and valine is preferably 1:1.5 to 2.5:0.8 to 1.7 and the daily dose is 2.0 g to 50.0 g.
    Type: Grant
    Filed: June 24, 2005
    Date of Patent: March 1, 2016
    Assignee: AJINOMOTO CO., INC.
    Inventors: Kiwamu Okita, Isao Sakaida, Yoshihiro Morinaga, Shoji Fujitani
  • Publication number: 20150353803
    Abstract: In a microcapsule having a latent heat storage material having no vinyl group as a core material and a cross-linked polymer as a shell material, functions of the latent heat storage material is stably and efficiently expressed.
    Type: Application
    Filed: January 10, 2014
    Publication date: December 10, 2015
    Inventors: Zhengzhe JIN, Tsutomu TAKASHIMA, Yoshihiro MORINAGA, Masaaki KOBAYASHI
  • Publication number: 20150108395
    Abstract: The present invention provides a paraffin-based latent heat storage material composition that includes, as a main component, a mixture of n-hexadecane, n-pentadecane, and, optionally, n-tetradecane, in which 1) the mixture has the n-hexadecane content of 68 mass % or more, the n-pentadecane content of 1 mass % to 23 mass %, and the n-tetradecane content of 23 mass % or less, where the total sum of the n-hexadecane content, the n-pentadecane content, and the n-tetradecane content is 100 mass %, 2) the composition has a melting point lower than that of n-hexadecane, and 3) the composition has a latent heat of fusion of 200 J/g or more.
    Type: Application
    Filed: May 28, 2013
    Publication date: April 23, 2015
    Inventors: Mizuho Yoshida, Yoshihiro Morinaga, Toshiyuki Tsutsumi
  • Patent number: 7973076
    Abstract: The present invention provides compositions having, as active ingredients, a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: July 5, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Publication number: 20100216755
    Abstract: The present application provides a method for the treatment of tumors where the lethal dose of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is increased to twice or more, the toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, gastrointestinal toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, hepatic toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, and/or cardiovascular toxicity at the pharmaceutically effective dosage of (Z)—N-[2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)vinyl]phenyl]-L-serinamide is reduced, by administering to a subject in need thereof a composition containing: (a) an effective amount of an anti-inflammatory active substance, wherein the anti-inflammatory active substance is a Dexamethasone selected from t
    Type: Application
    Filed: May 6, 2010
    Publication date: August 26, 2010
    Applicant: AJINOMOTO CO. INC
    Inventors: Yukio NIHEI, Yoshihiro Morinaga, Manabu Suzuki, Yasuyo Suga
  • Publication number: 20100069486
    Abstract: The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Application
    Filed: November 20, 2009
    Publication date: March 18, 2010
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Patent number: 7655696
    Abstract: The present invention provides composition having as active ingredients a stilbene derivatively and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Grant
    Filed: August 4, 2005
    Date of Patent: February 2, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Publication number: 20090093540
    Abstract: The present invention provides compositions having, as active ingredients, a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Application
    Filed: December 15, 2008
    Publication date: April 9, 2009
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yoshihiro MORINAGA, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Patent number: 6992106
    Abstract: The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: January 31, 2006
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Publication number: 20060004101
    Abstract: The present invention provides a prophylactic or therapeutic agent, a pharmaceutical composition and a health-promoting food, which are used for human or other animal for the inhibition of the onset or progress of liver cancer, namely, an inhibitor of the onset or progress of liver cancer, which contains isoleucine, leucine and valine as active ingredients, wherein the weight ratio of isoleucine, leucine and valine is preferably 1:1.5 to 2.5:0.8 to 1.7 and the daily dose is 2.0 g to 50.0 g.
    Type: Application
    Filed: June 24, 2005
    Publication date: January 5, 2006
    Applicant: AJINOMOTO CO. INC
    Inventors: Kiwamu Okita, Isao Sakaida, Yoshihiro Morinaga, Shoji Fujitani
  • Publication number: 20050281892
    Abstract: The present invention provides composition having as active ingredients a stilbene derivatively and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Application
    Filed: August 4, 2005
    Publication date: December 22, 2005
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Publication number: 20040192621
    Abstract: The present invention relates to an anti-tumor agent containing a tubulin polymerization-inhibitory active substance and an anti-inflammatory active substance. The present invention also relates to an anti-tumor pharmaceutical preparation containing one or more tubulin polymerization-inhibitory active substance and/or anti-inflammatory active substance, which can be individually combined with one or more additional tubulin polymerization-inhibitory active substance and/or anti-inflammatory active substance. The present invention also relates to methods and therapeutic regimens for administering the same to a subject in need thereof.
    Type: Application
    Filed: December 24, 2003
    Publication date: September 30, 2004
    Applicant: AJINOMOTO CO., INC
    Inventors: Yukio Nihei, Yoshihiro Morinaga, Manabu Suzuki, Yasuyo Suga
  • Publication number: 20020193362
    Abstract: The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Application
    Filed: June 12, 2002
    Publication date: December 19, 2002
    Applicant: AJINOMOTO CO. INC
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Publication number: 20020193434
    Abstract: The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Application
    Filed: May 29, 2002
    Publication date: December 19, 2002
    Applicant: AJINOMOTO CO. INC
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano
  • Patent number: 6462087
    Abstract: The present invention provides composition having as active ingredients a stilbene derivative and a platinum coordination compound which is highly efficacious and highly safe for treating tumors, particularly for the treatment of solid or malignant tumors and thus methods of cancer and tumor treatment using the composition are also provided.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: October 8, 2002
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yoshihiro Morinaga, Yukio Nihei, Yasuyo Suga, Manabu Suzuki, Kazuo Ohishi, Akira Okano